Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition.
about
Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Vildagliptin ameliorates pulmo ...... ial-to-mesenchymal transition.
@en
Vildagliptin ameliorates pulmo ...... ial-to-mesenchymal transition.
@nl
type
label
Vildagliptin ameliorates pulmo ...... ial-to-mesenchymal transition.
@en
Vildagliptin ameliorates pulmo ...... ial-to-mesenchymal transition.
@nl
prefLabel
Vildagliptin ameliorates pulmo ...... ial-to-mesenchymal transition.
@en
Vildagliptin ameliorates pulmo ...... ial-to-mesenchymal transition.
@nl
P2093
P2860
P921
P1433
P1476
Vildagliptin ameliorates pulmo ...... ial-to-mesenchymal transition.
@en
P2093
Iwao Shimomura
James West
Koichiro Tatsumi
Rintaro Nishimura
Santhi Gladson
Satoshi Karasawa
P2860
P2888
P356
10.1186/S12931-017-0660-4
P577
2017-10-16T00:00:00Z
P6179
1092243836